These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7594517

  • 21. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
    Uger RA, Barber BH.
    J Immunol; 1998 Feb 15; 160(4):1598-605. PubMed ID: 9469415
    [Abstract] [Full Text] [Related]

  • 22. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M, Vacchio MS, Hodes RJ, Berzofsky JA.
    J Immunol; 1993 Aug 15; 151(4):2283-95. PubMed ID: 7688397
    [Abstract] [Full Text] [Related]

  • 23. Induction of peptide-specific CD8+ CTL clones in beta 2-microglobulin-deficient mice.
    Cook JR, Solheim JC, Connolly JM, Hansen TH.
    J Immunol; 1995 Jan 01; 154(1):47-57. PubMed ID: 7995959
    [Abstract] [Full Text] [Related]

  • 24. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM, Bonneau RH, Epler M, Tevethia MJ, Alam S, Verner K, Tevethia SS.
    Virology; 1996 Aug 01; 222(1):269-74. PubMed ID: 8806508
    [Abstract] [Full Text] [Related]

  • 25. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
    Gad M, Jensen T, Gagne R, Komba S, Daugaard S, Kroman N, Meldal M, Werdelin O.
    Eur J Immunol; 2003 Jun 01; 33(6):1624-32. PubMed ID: 12778480
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes.
    Alexander J, Oseroff C, Sidney J, Wentworth P, Keogh E, Hermanson G, Chisari FV, Kubo RT, Grey HM, Sette A.
    J Immunol; 1997 Nov 15; 159(10):4753-61. PubMed ID: 9366399
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1.
    Pietersz GA, Li W, Osinski C, Apostolopoulos V, McKenzie IF.
    Vaccine; 2000 Apr 03; 18(19):2059-71. PubMed ID: 10706970
    [Abstract] [Full Text] [Related]

  • 35. MHC-unrestricted T-cell cytotoxicity against tumour cells.
    Sponaas AM, Loveland B, Simpson E.
    Immunology; 1988 Feb 03; 63(2):233-9. PubMed ID: 3258274
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Restricted blocking of cytotoxic T-cell function by anti-H-2K/D antibodies.
    O'Neill HC.
    Immunology; 1988 Feb 03; 63(2):241-6. PubMed ID: 3258275
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.